Valuation: Medicure Inc.

Market Cap 13.46M 9.48M 8.29M 7.61M 7.1M 902M 13.67M 91.42M 35.54M 444M 35.58M 34.81M 1.53B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 10.52M 7.41M 6.47M 5.95M 5.55M 705M 10.68M 71.43M 27.77M 347M 27.8M 27.2M 1.19B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.78%
1 week+0.78%
1 month+16.22%
3 months+15.18%
6 months+13.16%
Current year+13.16%
1 week 1.28
Extreme 1.28
1.29
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 1997-09-14
Director of Finance/CFO - 2022-05-31
Chief Tech/Sci/R&D Officer - 2019-06-30
Director TitleAgeSince
Chairman 79 1997-09-14
Director/Board Member 92 2000-02-27
Director/Board Member 56 2013-01-21
Date Insider Type Main position Quantity % Market Cap.
06-21Buy

Chief Executive Officer

1,000 0.0096%
06-21Buy

Chief Executive Officer

200 0.0019%
06-21Buy

Chief Executive Officer

2,500 0.0240%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+0.78%+3.20%+10.26% 9.49M
+0.68%+5.92%+80.45%+137.78% 58.73B
+2.32%+5.03%+75.51%+94.88% 53.92B
+3.86%+6.93%-11.32%-9.53% 24.67B
+4.30%+7.95%+14.11%+437.83% 24.19B
+4.74%+13.68%+45.58%-1.42% 18.8B
-0.29%+9.78%+44.62%-27.94% 17.61B
0.00%+20.78%+178.93%+360.74% 16.25B
+3.50%+1.97%+21.02%+191.95% 14.04B
+6.72%+19.38%+42.82% - 13.9B
Average +2.66%+6.80%+49.49%+132.73% 24.21B
Weighted average by Cap. +2.44%+5.62%+59.06%+138.48%

Financials

2024 2025
Net sales 21.91M 15.42M 13.48M 12.39M 11.55M 1.47B 22.24M 149M 57.83M 722M 57.89M 56.65M 2.49B 28.86M 20.32M 17.76M 16.32M 15.21M 1.93B 29.29M 196M 76.17M 951M 76.26M 74.62M 3.28B
Net income -1.04M -732K -639K -588K -548K -69.65M -1.05M -7.06M -2.74M -34.24M -2.75M -2.69M -118M -7.1M -5M -4.37M -4.01M -3.74M -476M -7.2M -48.19M -18.73M -234M -18.76M -18.35M -806M
Net Debt -6.32M -4.45M -3.89M -3.57M -3.33M -423M -6.41M -42.9M -16.68M -208M -16.69M -16.34M -717M -2.94M -2.07M -1.81M -1.67M -1.55M -197M -2.99M -19.99M -7.77M -97.01M -7.78M -7.61M -334M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
26-06-30 $1.290 +0.78% 1,140